Supplemental Hydrogen Plus PQQ for Mitochondrial Biomarkers and Brain Function in Elderly With Mild Cognitive Impairment — CALERIE

Age-associated Memory Impairment Clinical Trial

Official title:
The Effects of Six-week Hydrogen Plus Pyrroloquinoline Quinone (PQQ) Intake on Mitochondrial Biomarkers, Brain Metabolism and Cognition in the Elderly With Mild Cognitive Impairment

Status Recruiting

Clinical Trial Summary

The goal of this randomized controlled double-blind parallel-group interventional trial is to evaluate the effects of dietary supplementation with molecular hydrogen and pyrroloquinoline quinone in elderly. The main questions it aims to answer are: (1) whether the supplementation affects biomarkers of mitochondrial function in serum, and (2) whether the supplementation affects cognition and brain metabolism. The participants will be subjected to take the dietary supplement during 6 weeks.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05910047
Study type	Interventional
Source	University of Novi Sad, Faculty of Sport and Physical Education
Contact
Status	Recruiting
Phase	N/A
Start date	September 1, 2023
Completion date	March 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01429103` - Hormones and Cognition in the Menopausal Transition	N/A
Completed	`NCT05759910` - Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals	N/A
Completed	`NCT00355550` - Tricaprilin In Age-Associated Memory Impairment	Phase 2
Terminated	`NCT05462782` - TMS for Investigating Memory Facilitation	N/A
Recruiting	`NCT05934344` - Effectiveness of an Intervention Using Observation/Action Therapy Among Patients With Mild Cognitive Impairment	N/A